AGP Picks
View all

Middle East News Watch
Provided by AGP

Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 13, 2026

Altimmune Announces First Quarter 2026 Financial Results and Business Update
May 13, 2026

Altimmune Announces First Quarter 2026 Financial Results and Business Update

Indeterminate GlobeNewswire
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
May 13, 2026

Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions

Indeterminate GlobeNewswire
PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 13, 2026

PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results

Indeterminate GlobeNewswire
Tower Semiconductor Signs Customer Contracts for $1.3 Billion Silicon Photonics Revenue for 2027
May 13, 2026

Tower Semiconductor Signs Customer Contracts for $1.3 Billion Silicon Photonics Revenue for 2027

Indeterminate GlobeNewswire
Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
May 13, 2026

Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026

Indeterminate GlobeNewswire
Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
May 13, 2026

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Gilat Reports First Quarter 2026 Results
May 13, 2026

Gilat Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone
May 13, 2026

Nexentis Technologies Announces Optimization of Hit Molecule at MitoCareX Bio Representing Key Drug Discovery Milestone

Indeterminate GlobeNewswire
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
May 13, 2026

PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update

Indeterminate GlobeNewswire
Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 
May 13, 2026

Verano Submits DEA Registration Applications for State-Licensed Medical Cannabis Businesses Following Landmark Federal Rescheduling Order 

Indeterminate GlobeNewswire
BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026
May 13, 2026

BioCryst to Present New Real-World Evidence Underscoring the Ongoing Burden of Pediatric Hereditary Angioedema at ISPOR 2026

Indeterminate GlobeNewswire
Kornit Digital Reports First Quarter 2026 Results
May 13, 2026

Kornit Digital Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy
May 13, 2026

Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy

Indeterminate GlobeNewswire
Andera Partners Leads $20 Million Series D Financing in Rivermark Medical
May 13, 2026

Andera Partners Leads $20 Million Series D Financing in Rivermark Medical

Indeterminate GlobeNewswire
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year
May 13, 2026

Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year

Indeterminate GlobeNewswire
Tower Semiconductor Reports First Quarter 2026 Financial Results with 15% Year over Year Revenue Growth
May 13, 2026

Tower Semiconductor Reports First Quarter 2026 Financial Results with 15% Year over Year Revenue Growth

Indeterminate GlobeNewswire
Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor
May 13, 2026

Zenas BioPharma Announces First Subject Dosed in Phase 1 Clinical Trial of ZB021, a Novel, Potentially Best-in-Class Oral IL-17AA/AF Inhibitor

Indeterminate GlobeNewswire
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
May 13, 2026

Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress

Indeterminate GlobeNewswire
Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update
May 13, 2026

Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Indeterminate GlobeNewswire
Global-e Achieves “Rule of 50” Again with Meaningful GMV, Revenue and Profit Expansion in the First Quarter of 2026, Raises Outlook for the Year
May 13, 2026

Global-e Achieves “Rule of 50” Again with Meaningful GMV, Revenue and Profit Expansion in the First Quarter of 2026, Raises Outlook for the Year

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East News Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.